Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124954) titled 'Randomized Controlled Trial of Early Low-Dose Aspirin Use After Intravenous Thrombolysis in Acute Cerebral Infarction Patients' on May 19.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing Chao-Yang Hospital, Capital Medical University

Condition: Acute cerebral infarction

Intervention: Early use of aspirin group:Early use of aspirin after rt-PA thrombolysis

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-19

Target Sample Size: Early use of aspirin group:105;Control group:105;

Countries of Recruitment: China

To know more, visit https://...